ARCHIVES

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

NCI, ACS Agree On Interim Mammography Guides Dropping Routine Use for Women Under Age 50

August 27, 1976

MDV3100 Improves Survival, Reduces Death Risk by 37%

November 25, 2011

New Mexico, Michigan Win Saturation Implementation Contracts

June 6, 1975

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

March 27, 1998

FY’78 Construction Requests $44 Million, Budget At $12 Million

December 2, 1977

In Brief: Friends of Cancer Research Honor Specter; Dole Tapes Announcement For CaP CURE

January 24, 1997